Gilead Sciences

[video]A $1 Trillion Drug Market?
Motley Fool
Tue, 04/8/14 - 10:44 am
Gilead Sciences
Solvadi
hepatitis C
hepatitis B
A Physician-Businessman's Views Of Gilead, With Emphasis On Sovaldi
Seeking Alpha
Mon, 04/7/14 - 12:54 pm
physicians
Sovaldi
Gilead Sciences
hepatitis C
FirstWord Lists – The Quarterly: 10 key pharma events that occurred in Q1
First Word Pharma
Mon, 04/7/14 - 10:24 am
immuno-oncology
Sovaldi
Gilead Sciences
Teva Pharmaceuticals
Copaxone
GSK
Breo Ellipta
Forest Labs
Actavis
M&A
Affordable Care Act
biosimilars
PCSK9 inhibitors
Gilead says Japanese hepatitis C trial meets goal
Yahoo/Reuters
Wed, 04/2/14 - 10:01 pm
Gilead Sciences
Japan
hepatitis C
sofosbuvir
Gilead Sciences: What If Sovaldi Sales Peak Quickly, Fall Fast?
Barron's
Wed, 04/2/14 - 09:41 pm
Sovaldi
hepatitis C
Gilead Sciences
Biotechnology companies hunting for the keys to immortality
FT.com
Thu, 03/27/14 - 05:09 pm
Mesoblast
aging
Calico
AlloCure
stem cells
Gilead Sciences
Congress Makes Sovaldi A Scapegoat: The Cost-Innovation Paradox In The US Healthcare System
Forbes
Thu, 03/27/14 - 10:58 am
Gilead Sciences
drug pricing
Sovaldi
US Congress
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
Seeking Alpha
Wed, 03/26/14 - 08:30 am
AbbVie
Amgen
Gilead Sciences
Achillion
Alexion
Ariad Pharmaceuticals
Pharmacyclics
Seattle Genetics
Gilead Following Multiple Paths Toward HIV “Functional Cure”
Motley Fool
Tue, 03/25/14 - 08:01 pm
Gilead Sciences
HIV
Will The Hep-C Drug, Sovaldi, Drive Gilead To The Top Of The Biopharm Industry?
Forbes
Tue, 03/25/14 - 08:05 am
hepatitis C
Gilead Sciences
Sovaldi
Sovaldi's Patent War
Seeking Alpha
Mon, 03/24/14 - 06:00 pm
Sovaldi
Gilead Sciences
hepatitis C
patents
JPMorgan Sees No Bubble, Hears No Bubble as Biotech Falls Again
Barron's
Mon, 03/24/14 - 11:29 am
biotech
Biogen Idec
Amgen
Celgene
Gilead Sciences
Regeneron
One Of Pharma's Biggest Enemies Goes After The Future's Best-Selling Drug
Forbes
Mon, 03/24/14 - 08:52 am
drug pricing
Henry Waxman
Sovaldi
Gilead Sciences
Gilead offers Egypt new hepatitis C drug at 99 pct discount
Yahoo/Reuters
Sat, 03/22/14 - 11:48 am
Gilead Sciences
hepatitis C
Sovaldi
Biotech Tweets of the Week: Gilead Sciences and Orexigen
Motley Fool
Sat, 03/22/14 - 11:32 am
Gilead Sciences
Orexigen
Biotech Stocks Weak on Fear That Gilead Drug Pricing Woes Will Spread
TheStreet.com
Fri, 03/21/14 - 11:56 am
drug pricing
Gilead Sciences
Sovaldi
biotech
hepatitis C
What the Heck Happened (Again) to Biotech?
Barron's
Fri, 03/21/14 - 11:55 am
biotech
Gilead Sciences
Biogen Idec
U.S. lawmakers ask Gilead about Sovaldi pricing
Yahoo/Reuters
Fri, 03/21/14 - 11:54 am
drug pricing
Sovaldi
hepatitis C
Gilead Sciences
Read This Twitter Chat About Gilead and the Cost of its Hep C Drug
TheStreet.com
Fri, 03/21/14 - 09:02 am
social media
twitter
hepatitis C
Sovaldi
Gilead Sciences
drug pricing
Pharmacyclics Drug Imbruvica Beats Rivals: Nomura
Investors.com
Thu, 03/20/14 - 05:26 pm
Imbruvica
Pharmacyclics
Gilead Sciences
Biogen Idec
chronic lymphocytic leukemia

Pages